Commercial color decisions are rarely made before initial stability studies — which can result in costly delays if new colors are introduced. And one major concern when developing a new drug is the ability to anticipate upfront interactions between fill and capsule.
Colorista® capsules are a new single R&D solution for pharmaceutical formulation development. It allows the ability to progress with compatibility and stability testing before deciding on a color for the commercial drug product. Colorista® capsules are the perfect tool for pharmaceutical customers who are looking for flexible and time-efficient development of new products or generics.
Capsugel® Colorista® is available in Coni-Snap® gelatin and Vcaps® Plus capsules which contains a selection of colorants and printing inks with a broad geographic scope. It is an optimized tool for formulation development and enabling compatibility studies before deciding on the final color for the commercial drug products.*
Helps cut development time
Enables great flexibility in stability and compatibility testing
Wide color selection
Over 150 colors available in gelatin
Over 50 colors available in HPMC (Vcaps® Plus)
Available in multiple sizes (in both gelatin and HPMC)
0, 1, and 2
Other sizes can be produced on demand
Solid functionality and performance
Resistance to fading
Exceptional color lab services
Advice on regulatory colorant compliance in intended markets
Outstanding color development, matching and customization capabilities
*Data generated using Capsugel® Colorista® capsules can be used for regulatory submission, provided that the color composition of the final drug product contains only colorants from the Colorista® capsule color formulation in an amount that does not exceed the original amount.
By using stability data from the Capsugel® Colorista® capsules to support the marketing authorization application, time can be gained in obtaining regulatory approval.
Colorista® is a trademark of Lonza or its affiliates registered in US and/or EU.